Mar 3, 2026
A joint video highlighting how digital biomarkers and real-world data support patient-centred healthcare across three disease areas
What happens when a disease enters someone’s life and changes everything?
Millions of people live with chronic conditions that shape their daily routines – often in ways that are invisible to others. Early diagnosis, timely intervention and more effective care can make a profound difference.
In a new joint video developed with support from the European Commission’s Booster initiative, the EU-funded projects iPROLEPSIS, AI-PROGNOSIS and REBECCA present a shared vision for patient-centred artificial intelligence in healthcare.
The video highlights how AI and digital biomarkers can enable earlier prediction, continuous monitoring and more personalised care across three disease areas:
Psoriatic arthritis (iPROLEPSIS)
Parkinson’s disease (AI-PROGNOSIS)
Breast cancer survivorship (REBECCA)
By integrating real-world behavioural data, wearable sensor signals and patient-reported information, the projects demonstrate how complex health data can be transformed into actionable clinical insights. These AI-driven approaches aim to strengthen clinical decision-making while keeping patients at the centre of care.
The video reflects the projects’ commitment to developing trustworthy, responsible and co-designed AI solutions that respond to real clinical and patient needs.
Watch the video here:
To learn more, visit:
iPROLEPSIS – https://www.iprolepsis.eu
AI-PROGNOSIS – https://www.ai-prognosis.eu
REBECCA – https://www.rebeccaproject.eu
